These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 22961090)

  • 1. Leflunomide: friend or foe for systemic lupus erythematosus?
    Wu GC; Xu XD; Huang Q; Wu H
    Rheumatol Int; 2013 Feb; 33(2):273-6. PubMed ID: 22961090
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The beneficial effect of leflunomide on systemic lupus erythematosus: the role of Tregs repopulation?: Comment on: Leflunomide: friend or foe for systemic lupus erythematosus? Rheumatol Int 2013, 33(2):273-6.
    Shin JI
    Rheumatol Int; 2014 Jun; 34(6):881. PubMed ID: 23765200
    [No Abstract]   [Full Text] [Related]  

  • 3. [Leflunomide in systemic lupus erythematosus].
    Kessel A; Toubi E
    Harefuah; 2002 Apr; 141(4):355-7, 409. PubMed ID: 12017890
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Leflunomide for the treatment of systemic lupus erythematosus: comment on the article by McMurray.
    Barthel HR
    Arthritis Rheum; 2001 Oct; 45(5):472. PubMed ID: 11642648
    [No Abstract]   [Full Text] [Related]  

  • 5. Analysis of changes in joint function and peripheral blood mononuclear cells in patients with systemic lupus erythematosus and intervention effects of different drugs.
    Zhou QS; Hu J; Hu H
    Eur Rev Med Pharmacol Sci; 2017 Oct; 21(19):4423-4430. PubMed ID: 29077150
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Double-blind, randomized, placebo-controlled pilot study of leflunomide in systemic lupus erythematosus.
    Tam LS; Li EK; Wong CK; Lam CW; Szeto CC
    Lupus; 2004; 13(8):601-4. PubMed ID: 15462490
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Collagen diseases and rheumatic diseases].
    Takeuchi T; Amano K; Tsuzake K; Kameda H; Abe T
    Nihon Naika Gakkai Zasshi; 2004 Mar; 93(3):538-44. PubMed ID: 15052817
    [No Abstract]   [Full Text] [Related]  

  • 8. Leflunomide-induced subacute cutaneous lupus erythematosus with erythema multiforme-like lesions.
    Marzano AV; Ramoni S; Del Papa N; Barbareschi M; Alessi E
    Lupus; 2008 Apr; 17(4):329-31. PubMed ID: 18413415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. How to treat refractory arthritis in lupus?
    Artifoni M; Puéchal X
    Joint Bone Spine; 2012 Jul; 79(4):347-50. PubMed ID: 22341583
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Leflunomide: A safe and effective alternative in systemic lupus erythematosus.
    Carrión-Barberà I; Polino L; Mejía-Torres M; Pérez-García C; Ciria M; Pros A; Rodríguez-García E; Monfort J; Salman-Monte TC
    Autoimmun Rev; 2022 Feb; 21(2):102960. PubMed ID: 34560304
    [No Abstract]   [Full Text] [Related]  

  • 11. [Leflunomide--a new drug for pharmacological immunomodulation].
    Wozel G; Pfeiffer C
    Hautarzt; 2002 May; 53(5):309-15. PubMed ID: 12063741
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Benefits of leflunomide in systemic lupus erythematosus: a pilot observational study.
    Remer CF; Weisman MH; Wallace DJ
    Lupus; 2001; 10(7):480-3. PubMed ID: 11480845
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Leflunomide.
    Cannon GW; Kremer JM
    Rheum Dis Clin North Am; 2004 May; 30(2):295-309, vi. PubMed ID: 15172042
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of Leflunomide on the Abnormal Expression of Lipid Rafts and F-Actin in B Lymphocytes from Patients with Systemic Lupus Erythematosus.
    Dong GF; Zhang X; He DN; Li L; Zhang GF
    J Immunol Res; 2015; 2015():832916. PubMed ID: 26090500
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Benefit/risk of leflunomide in rheumatoid arthritis.
    Kremer JM; Cannon GW
    Clin Exp Rheumatol; 2004; 22(5 Suppl 35):S95-100. PubMed ID: 15552521
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disease modifying activity of HWA 486 on the development of SLE in MRL/1-mice.
    Popovic S; Bartlett RR
    Agents Actions; 1986 Dec; 19(5-6):313-4. PubMed ID: 3825747
    [No Abstract]   [Full Text] [Related]  

  • 17. Rheumatoid arthritis and the Arava (leflunomide) controversy.
    Turkoski BB
    Orthop Nurs; 2003; 22(1):48-51. PubMed ID: 12640952
    [No Abstract]   [Full Text] [Related]  

  • 18. Efficacy and safety of leflunomide in active rheumatoid arthritis.
    Smolen JS; Emery P
    Rheumatology (Oxford); 2000 Jun; 39 Suppl 1():48-56. PubMed ID: 11001380
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The efficacy and safety of leflunomide therapy in lupus nephritis by repeat kidney biopsy.
    Zhang FS; Nie YK; Jin XM; Yu HM; Li YN; Sun Y
    Rheumatol Int; 2009 Sep; 29(11):1331-5. PubMed ID: 19169882
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of the murine chronic graft vs host (CGVH) disease, a model for systemic lupus erythematosus (SLE), for drug discovery.
    Popovic S; Bartlett RR
    Agents Actions; 1987 Aug; 21(3-4):284-6. PubMed ID: 3687582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.